JPRN-UMIN000020203已完成未知
Study of a heart failure treatment using a combination drug consisting of reduced coenzyme Q10, astaxanthin, citrulline, and zinc - Study of a heart failure treatment using a combination drug consisting of reduced coenzyme Q10, astaxanthin, citrulline, and zinc
Tokorozawa Heart Center, Medical Corporation Ouyuukai0 个研究点目标入组 50 人开始时间: 2015年12月15日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1)Patients who meet the following criteria are excluded: those who have not completely recovered from a malignancy; with severe infection; suspected of having a pulmonary disease (including COPD) on a chest radiogram; who are on dialysis; and others who are found unacceptable at the discretion of the physician (2)Patients who have taken drugs or supplements including coenzyme Q10, astaxanthin, and citrulline within the last 2 months
研究者
相似试验
已完成
不适用
Pilot study for the treatment of heart failure with PycnogenolCirculatory SystemHeart failureISRCTN22412590Kyoto University (Japan)30
尚未招募
不适用
Clinical study on intervention of heart failure patients after myocardial infarction with Wuqinxi based on the theory of ''supporting yang''Postinfarction heart failureITMCTR2022000105Guang'anmen Hospital, Chinese Academy of traditional Chinese Medicine
已完成
不适用
eural Cardiac Therapy for Heart Failure Studycardiac remodeling10019280Heart failureNL-OMON46859Boston Scientific20
已完成
不适用
Comparing the treatment of heart failure patients in primary and secondary careCardiovascular: Chronic heart failure (CHF)Circulatory SystemChronic heart failure (CHF)ISRCTN48337167Department of Health
尚未招募
1 期
Clinical observation trial of Anti-heart Failure Intelligent Formula Kingchronic heart failureITMCTR2200006012Guang'anmen Hospital of China Academy of Chinese Medical Sciences